Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1970 1
1971 5
1972 5
1973 4
1974 4
1975 5
1976 5
1977 6
1978 3
1979 6
1980 6
1981 3
1982 12
1983 16
1984 5
1985 12
1986 8
1987 11
1988 9
1989 16
1990 17
1991 13
1992 19
1993 17
1994 10
1995 22
1996 19
1997 15
1998 14
1999 19
2000 26
2001 20
2002 17
2003 20
2004 22
2005 21
2006 20
2007 13
2008 19
2009 9
2010 5
2011 3
2012 15
2013 11
2014 7
2015 8
2016 8
2017 8
2018 6
2019 6
2020 11
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

568 results
Results by year
Filters applied: . Clear all
Page 1
Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma.
Illhardt T, Toporski J, Feuchtinger T, Turkiewicz D, Teltschik HM, Ebinger M, Schwarze CP, Holzer U, Lode HN, Albert MH, Gruhn B, Urban C, Dykes JH, Teuffel O, Schumm M, Handgretinger R, Lang P. Illhardt T, et al. Among authors: lode hn. Biol Blood Marrow Transplant. 2018 May;24(5):1005-1012. doi: 10.1016/j.bbmt.2017.12.805. Epub 2018 Jan 4. Biol Blood Marrow Transplant. 2018. PMID: 29307718 Free article. Clinical Trial.
Risks associated with the therapeutic use of fluoroquinolones.
Stahlmann R, Lode HM. Stahlmann R, et al. Among authors: lode hm. Expert Opin Drug Saf. 2013 Jul;12(4):497-505. doi: 10.1517/14740338.2013.796362. Epub 2013 May 7. Expert Opin Drug Saf. 2013. PMID: 23651367 Review.
2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors.
Simon T, Hero B, Schulte JH, Deubzer H, Hundsdoerfer P, von Schweinitz D, Fuchs J, Schmidt M, Prasad V, Krug B, Timmermann B, Leuschner I, Fischer M, Langer T, Astrahantseff K, Berthold F, Lode H, Eggert A. Simon T, et al. Among authors: lode h. Klin Padiatr. 2017 May;229(3):147-167. doi: 10.1055/s-0043-103086. Epub 2017 May 30. Klin Padiatr. 2017. PMID: 28561228 English.
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1).
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Ash S, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chi Fung Chan G, Ruud E, Schroeder H, Beck-Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: lode hn. Cancers (Basel). 2020 Jan 28;12(2):309. doi: 10.3390/cancers12020309. Cancers (Basel). 2020. PMID: 32013055 Free PMC article.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: lode hn. Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442501 Clinical Trial.
Impact of Bacterial Toxins in the Lungs.
Lucas R, Hadizamani Y, Gonzales J, Gorshkov B, Bodmer T, Berthiaume Y, Moehrlen U, Lode H, Huwer H, Hudel M, Mraheil MA, Toque HAF, Chakraborty T, Hamacher J. Lucas R, et al. Among authors: lode h. Toxins (Basel). 2020 Apr 2;12(4):223. doi: 10.3390/toxins12040223. Toxins (Basel). 2020. PMID: 32252376 Free PMC article. Review.
[Pneumonia].
Lode H, Schaberg T. Lode H, et al. Pneumologie. 1996 Sep;50 Suppl 2:592-4. Pneumologie. 1996. PMID: 9157422 Review. German. No abstract available.
568 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page